Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive symbols : Bntx save search
Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.39%
H: 2.48%
C: 1.8%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.99%
H: 1.81%
C: 0.47%
covid-19 vaccine positive influenza topline program
BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023
Published: 2023-10-23 (Crawled : 15:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -0.48%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.24%
H: 7.12%
C: 4.11%
bnt211 candidate congress tumors positive update cell car-t therapy
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union
Published: 2023-08-30 (Crawled : 14:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
covid-19 chmp vaccine positive
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO
Published: 2023-06-02 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.05%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 3.21%
H: 2.0%
C: 0.62%
bnt316 candidate antibody asco positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published: 2022-11-10 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.15%
H: 4.22%
C: 4.22%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 1.72%
H: 0.47%
C: -0.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -4.59%
H: 3.28%
C: 3.06%
covid-19 chmp children vaccine positive
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Published: 2022-10-19 (Crawled : 16:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.41%
H: 0.36%
C: -1.82%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.37%
H: 0.37%
C: -6.97%
comirnaty comirnaty® chmp children positive
Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older
Published: 2022-10-13 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: -4.1%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.78%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.64%
H: 3.35%
C: 2.92%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.2%
H: 6.32%
C: 4.76%
trial positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union
Published: 2022-09-16 (Crawled : 12:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.74%
H: 0.91%
C: -0.74%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.33%
H: 1.15%
C: -0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.52%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.82%
H: 3.27%
C: 3.0%
comirnaty comirnaty® chmp authorization positive
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union
Published: 2022-09-01 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -4.51%
H: 1.07%
C: 1.07%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.2%
H: 3.35%
C: 3.3%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -3.04%
H: 0.45%
C: 0.05%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.68%
H: 1.61%
C: 1.5%
covid-19 chmp vaccine positive
Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunotherapy in Patients with Resected Pancreatic Cancer presented at ASCO
Published: 2022-06-05 (Crawled : 20:20) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
| Email alert
Add to watchlist
immunotherapy asco positive cancer pancreatic phase 1
Pfizer, BioNTech Seek Approval for Boosters in Children Following Positive Data
Published: 2022-04-14 (Crawled : 15:20) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.67%
H: 1.98%
C: -1.62%
children approval positive
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACR
Published: 2022-04-11 (Crawled : 08:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 4.5%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -2.44%
H: 3.61%
C: 2.68%
bnt211 car-t program positive phase 1
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
Published: 2021-11-25 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
comirnaty comirnaty® europe positive chmp children
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -8.02%
H: 3.64%
C: -0.64%
covid positive results topline children vaccine trial
Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Published: 2021-03-31 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.59%
H: 0.36%
C: 0.12%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 4.81%
H: 1.4%
C: -0.25%
covid positive results topline vaccine covid-19
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Published: 2020-12-21 (Crawled : 15:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -1.06%
H: 0.32%
C: 0.27%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 3.14%
H: 0.43%
C: -0.98%
covid vaccine positive chmp covid-19
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.